The c‐MET expression was noticed to be an independent prognostic marker and a potential therapeutic target especially in ccRCC, associated with worse disease-specific survival [23] due to aggressive tumor behavior [24] and increased PD-L1 expression [21]. The gene discussed is CD274; the disease is nonpapillary renal cell carcinoma.